vs
Mativ Holdings, Inc.（MATV）とSotera Health Co（SHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Mativ Holdings, Inc.の直近四半期売上が大きい（$463.1M vs $303.4M、Sotera Health Coの約1.5倍）。Mativ Holdings, Inc.の純利益率が高く（21.8% vs 11.5%、差は10.3%）。Sotera Health Coの前年同期比売上増加率が高い（4.6% vs 1.0%）。Sotera Health Coの直近四半期フリーキャッシュフローが多い（$52.4M vs $8.0M）。過去8四半期でSotera Health Coの売上複合成長率が高い（10.6% vs -3.8%）
Mativ Holdings, Inc.は世界的な特殊材料メーカーで、高性能先端ポリマー、不織布、ろ過ソリューション、機能性コーティング材料を製造しています。医療、産業、消費財、航空宇宙、エネルギー分野に顧客を持ち、北米、欧州、アジア太平洋地域で事業を展開しています。
Sotera Health Coは医療安全ソリューションをグローバルに提供する企業で、医療機器メーカー、製薬会社、食品・消費財企業を対象に滅菌サービス、分析検査、規制対応コンサルティングを提供し、顧客の製品安全性確保と基準準拠を支援しています。
MATV vs SHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $463.1M | $303.4M |
| 純利益 | $100.8M | $34.8M |
| 粗利率 | 18.8% | 54.7% |
| 営業利益率 | 2.2% | 23.2% |
| 純利益率 | 21.8% | 11.5% |
| 売上前年比 | 1.0% | 4.6% |
| 純利益前年比 | 6620.0% | 182.8% |
| EPS（希薄化後） | $1.87 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $463.1M | $303.4M | ||
| Q3 25 | $513.7M | $311.3M | ||
| Q2 25 | $525.4M | $294.3M | ||
| Q1 25 | $484.8M | $254.5M | ||
| Q4 24 | $458.6M | $290.2M | ||
| Q3 24 | $498.5M | $285.5M | ||
| Q2 24 | $523.8M | $276.6M | ||
| Q1 24 | $500.2M | $248.2M |
| Q4 25 | $100.8M | $34.8M | ||
| Q3 25 | $-3.2M | $48.4M | ||
| Q2 25 | $-9.5M | $8.0M | ||
| Q1 25 | $-425.5M | $-13.3M | ||
| Q4 24 | $1.5M | $12.3M | ||
| Q3 24 | $-20.8M | $17.0M | ||
| Q2 24 | $-1.4M | $8.8M | ||
| Q1 24 | $-28.0M | $6.3M |
| Q4 25 | 18.8% | 54.7% | ||
| Q3 25 | 19.3% | 57.0% | ||
| Q2 25 | 19.7% | 56.6% | ||
| Q1 25 | 15.0% | 53.2% | ||
| Q4 24 | 16.9% | 56.6% | ||
| Q3 24 | 18.8% | 55.4% | ||
| Q2 24 | 20.8% | 55.2% | ||
| Q1 24 | 16.8% | 51.2% |
| Q4 25 | 2.2% | 23.2% | ||
| Q3 25 | 3.1% | 23.4% | ||
| Q2 25 | 3.8% | 6.4% | ||
| Q1 25 | -88.8% | -5.8% | ||
| Q4 24 | 0.6% | 30.0% | ||
| Q3 24 | 1.4% | 28.2% | ||
| Q2 24 | 2.0% | 27.8% | ||
| Q1 24 | -2.8% | 21.4% |
| Q4 25 | 21.8% | 11.5% | ||
| Q3 25 | -0.6% | 15.5% | ||
| Q2 25 | -1.8% | 2.7% | ||
| Q1 25 | -87.8% | -5.2% | ||
| Q4 24 | 0.3% | 4.2% | ||
| Q3 24 | -4.2% | 6.0% | ||
| Q2 24 | -0.3% | 3.2% | ||
| Q1 24 | -5.6% | 2.5% |
| Q4 25 | $1.87 | $0.12 | ||
| Q3 25 | $-0.06 | $0.17 | ||
| Q2 25 | $-0.18 | $0.03 | ||
| Q1 25 | $-7.82 | $-0.05 | ||
| Q4 24 | $0.03 | $0.05 | ||
| Q3 24 | $-0.38 | $0.06 | ||
| Q2 24 | $-0.03 | $0.03 | ||
| Q1 24 | $-0.52 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $84.2M | $344.6M |
| 総負債低いほど良い | $1.0B | $2.1B |
| 株主資本純資産 | $498.7M | $606.0M |
| 総資産 | $2.1B | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | 2.07× | 3.53× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $84.2M | $344.6M | ||
| Q3 25 | $97.1M | $299.2M | ||
| Q2 25 | $95.6M | $332.4M | ||
| Q1 25 | $84.0M | $304.4M | ||
| Q4 24 | $94.3M | $277.2M | ||
| Q3 24 | $162.2M | $306.7M | ||
| Q2 24 | $133.4M | $246.1M | ||
| Q1 24 | $128.9M | $261.1M |
| Q4 25 | $1.0B | $2.1B | ||
| Q3 25 | $1.0B | $2.1B | ||
| Q2 25 | $1.1B | $2.2B | ||
| Q1 25 | $1.1B | $2.2B | ||
| Q4 24 | $1.1B | $2.2B | ||
| Q3 24 | $1.2B | $2.2B | ||
| Q2 24 | $1.2B | $2.2B | ||
| Q1 24 | $1.2B | $2.2B |
| Q4 25 | $498.7M | $606.0M | ||
| Q3 25 | $397.4M | $550.5M | ||
| Q2 25 | $416.6M | $511.3M | ||
| Q1 25 | $428.2M | $414.1M | ||
| Q4 24 | $858.5M | $404.9M | ||
| Q3 24 | $882.3M | $470.2M | ||
| Q2 24 | $898.0M | $422.8M | ||
| Q1 24 | $906.9M | $429.4M |
| Q4 25 | $2.1B | $3.3B | ||
| Q3 25 | $2.0B | $3.2B | ||
| Q2 25 | $2.1B | $3.2B | ||
| Q1 25 | $2.1B | $3.1B | ||
| Q4 24 | $2.4B | $3.1B | ||
| Q3 24 | $2.6B | $3.1B | ||
| Q2 24 | $2.6B | $3.1B | ||
| Q1 24 | $2.7B | $3.1B |
| Q4 25 | 2.07× | 3.53× | ||
| Q3 25 | 2.63× | 3.89× | ||
| Q2 25 | 2.66× | 4.34× | ||
| Q1 25 | 2.67× | 5.36× | ||
| Q4 24 | 1.30× | 5.49× | ||
| Q3 24 | 1.32× | 4.73× | ||
| Q2 24 | 1.29× | 5.26× | ||
| Q1 24 | 1.30× | 5.19× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $19.3M | $103.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $8.0M | $52.4M |
| FCFマージンFCF / 売上 | 1.7% | 17.3% |
| 設備投資強度設備投資 / 売上 | 2.4% | 16.7% |
| キャッシュ転換率営業CF / 純利益 | 0.19× | 2.96× |
| 直近12ヶ月FCF直近4四半期 | $93.8M | $149.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $19.3M | $103.1M | ||
| Q3 25 | $72.8M | $71.2M | ||
| Q2 25 | $57.6M | $57.4M | ||
| Q1 25 | $-15.9M | $55.5M | ||
| Q4 24 | $24.1M | $55.7M | ||
| Q3 24 | $37.6M | $97.5M | ||
| Q2 24 | $46.1M | $61.3M | ||
| Q1 24 | $-13.0M | $9.7M |
| Q4 25 | $8.0M | $52.4M | ||
| Q3 25 | $66.7M | $35.0M | ||
| Q2 25 | $48.9M | $26.2M | ||
| Q1 25 | $-29.8M | $35.6M | ||
| Q4 24 | $2.0M | $-10.2M | ||
| Q3 24 | $25.5M | $61.1M | ||
| Q2 24 | $37.4M | $19.4M | ||
| Q1 24 | $-25.1M | $-25.2M |
| Q4 25 | 1.7% | 17.3% | ||
| Q3 25 | 13.0% | 11.2% | ||
| Q2 25 | 9.3% | 8.9% | ||
| Q1 25 | -6.1% | 14.0% | ||
| Q4 24 | 0.4% | -3.5% | ||
| Q3 24 | 5.1% | 21.4% | ||
| Q2 24 | 7.1% | 7.0% | ||
| Q1 24 | -5.0% | -10.2% |
| Q4 25 | 2.4% | 16.7% | ||
| Q3 25 | 1.2% | 11.6% | ||
| Q2 25 | 1.7% | 10.6% | ||
| Q1 25 | 2.9% | 7.8% | ||
| Q4 24 | 4.8% | 22.7% | ||
| Q3 24 | 2.4% | 12.7% | ||
| Q2 24 | 1.7% | 15.2% | ||
| Q1 24 | 2.4% | 14.1% |
| Q4 25 | 0.19× | 2.96× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 7.21× | ||
| Q1 25 | — | — | ||
| Q4 24 | 16.07× | 4.52× | ||
| Q3 24 | — | 5.73× | ||
| Q2 24 | — | 7.00× | ||
| Q1 24 | — | 1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MATV
| Other | $208.7M | 45% |
| SAS Segment | $157.4M | 34% |
| FAM Segment | $97.0M | 21% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
